Alexis Régent

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia

Olivier Hermine, Xavier Mariette, Pierre‐Louis Tharaux et al. · JAMA Internal Medicine · 2020 · 777 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +14

T Cell Polarization toward TH2/TFH2 and TH17/TFH17 in Patients with IgG4-Related Disease

A. Grados, Mikaël Ebbo, Christelle Pipéroglou et al. · Frontiers in Immunology · 2017 · 100 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Risk factors for hydroxychloroquine retinopathy in systemic lupus erythematosus: a case–control study with hydroxychloroquine blood-level analysis

Tiphaine Lenfant, Gaëlle Leroux, Elodie Bousquet et al. · Lara D. Veeken · 2020 · 49 citations · Full text

Health Professions, Ophthalmology, Pharmacotherapy +13

Efficacy and safety of ustekinumab in Behçet disease: Results from the prospective phase 2 STELABEC trial

Jonathan London, Alexis Régent, Jérémie Dion et al. · Journal of the American Academy of Dermatology · 2021 · 22 citations

Life Sciences, Clinical Sciences, Immunology +8

Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational study

Anne Murarasu, G. Guettrot-Imbert, Véronique Le Guern et al. · The Lancet Rheumatology · 2022 · 22 citations

Medicine, Maternal Health, Obstetrics +17